Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

NCT00499694 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: satraplatin

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]